subclonal evolution and cytogenetic aberrations in myeloma
Published 2 years ago • 112 plays • Length 1:52Download video MP4
Download video MP3
Similar videos
-
1:16
the evolving use of selinexor in multiple myeloma
-
2:10
the temporal evolution of chromosome 1q gain and hyperdiploidy in multiple myeloma
-
2:25
new insight into the biology of multiple myeloma: from clonal evolution to new treatment options
-
0:59
defining the origins of multiple myeloma
-
9:56
multiple myeloma pathogenesis of clinical symptoms. crab criteria. amyloidosis. immunodeficiency.
-
3:16
end stage multiple myeloma
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
1:38
the genomic definition of high-risk myeloma
-
2:41
identification of myeloma high-risk subclones with single-cell technologies
-
5:20
the evolution of clonal hematopoiesis and associated outcomes in multiple myeloma
-
1:59
a subgroup analysis of majestec-1: teclistamab in multiple myeloma with high-risk features
-
1:17
the genetics of multiple myeloma and how we can use it to improve outcomes
-
2:31
gene expression profiles in subtype characterization and disease evolution of wm
-
1:11
advances that have been made in the molecular characterization of multiple myeloma
-
1:30
the genomic definition of ultra-high-risk multiple myeloma
-
3:02
the genetics of different stages of myeloma
-
1:29
insights into the biology of high-risk myeloma and advances being made in this space
-
1:50
molecular characteristics of extramedullary myeloma
-
9:32
multiple myeloma: genomic evolution
-
3:00
processes leading to the development of hyperdiploidy in multiple myeloma
-
2:46
managing patients with high-risk myeloma